Saturday, July 25, 2015

10 Best Bank Stocks To Buy Right Now

10 Best Bank Stocks To Buy Right Now: M&T Bank Corporation (MTB)

M&T Bank Corporation operates as the holding company for M&T Bank and M&T Bank, National Association that provide commercial and retail banking services to individuals, corporations and other businesses, and institutions. It offers business loans and leases; business credit cards; deposit products, such as demand, savings, and time accounts; and financial services, including cash management, payroll and direct deposit, merchant credit card, and letters of credit. The company also provides residential real estate loans; multifamily commercial real estate loans; commercial real estate loans; one-to-four family residential mortgage loans; investment and trading securities; short-term and long-term borrowed funds; brokered certificates of deposit and interest rate swap agreements related thereto; and branch deposits. In addition, it offers foreign exchange, as well as asset management services. Further, the company provides consumer loans, and commercial loans and leases; cred it life, and accident and health reinsurance; and securities brokerage, investment advisory, and insurance agency services. As of December 31, 2009, it had 738 banking offices in New York State, Pennsylvania, Maryland, Delaware, New Jersey, Virginia, West Virginia, and the District of Columbia; a commercial banking office in Ontario, Canada; and an office in George Town, Cayman Islands. The company was founded in 1969 and is headquartered in Buffalo, New York.

Advisors' Opinion:
  • [By Jonas Elmerraji]

    The most-hated name on our list today is M&T Bank (MTB), the $16 billion regional banking stock that tips the scales as one of the 20 largest banks in the country (and is one of Warren Buffett's favorite stocks). With a short interest ratio of 27.22, it would take more than five weeks of buying pressure for short sellers to exit their b! ets at current volume levels. That means that just about any catalyst could trigger a short squeeze right now.

    M&T Bank was one of the well-run regional names that actually fared well in the wake of the 2008 financial crisis. By actually sticking to retail and commercial banking and maintaining better underwriting standards, MTB ended up with a loan book that was high enough quality to make it through the lean years. Like other banking names, MTB sought to grow its business by acquiring smaller banking names -- and that's one of the big black clouds that investors are fixating on right now. Shares are seeing high short interest thanks to a regulatory edits to improve risk management and a pending acquisition of Hudson City Bancorp (HCBK) that's been a debacle.

    All of that negative sentiment has been piling up for the last two years (meanwhile, net margins are consistently above 25% and shares have actually managed to rally more than 62% over that stretch). The sheet amount of event risk surrounding earnings and the Hudson City merger make the prospect of being short here pretty scary. As soon as shorts start covering, expect a chain reaction.

    Read More: 12 Stocks Warren Buffett Loves in 2014

  • [By John Maxfield]

    They are Wells Fargo (NYSE: WFC  ) , U.S. Bancorp (NYSE: USB  ) , and M&T Bank (NYSE: MTB  ) . As you can see in the preceding table, all three of these banks perform at or near the top of their peer group in at least two out of the three variables.

  • [By , DividendChannel.com]

    Looking at the universe of stocks we cover at Dividend Channel, on May 28, First Financial Bancorp (FFBC), Goldman Sachs (GS) and M & T Bank Corp. (MTB) will all trade ex-dividend for their respective upcoming dividends. First Financial Bancorp will pay its quarterly dividend of $0.15 on July 1, Goldman Sachs will pay its quarterly dividend of $0.55 on June 27 and M & T Bank will pay its quarterly divid! end of $0! .70 on June 30.

  • [By Mike Deane]

    M&T Bank (MTB) announced its fourth quarter and full year earnings before the bell on Friday, with quarterly GAAP earnings falling from last year’s Q4 while full year earnings rose 11%.

    MTB Earnings in Brief

    M&T Bank reported quarterly net income of $245.72 million, which was down from last year’s Q4 net income of $296.19 million. The company’s diluted EPS came in at $1.79 for the quarter, down from the $2.23 per diluted common share reported in last year’s Q4 results. MTB missed analysts’ estimates of $1.92 EPS. For the full year, MTB reported EPS of $8.38, marking an 11% increase from last year’s EPS of $7.54

    CFO Commentary

    Rene F. Jones, CFO and executive VP, had the following comments about the company’s earnings: “While expenses were elevated by investments in our infrastructure during 2013, M&T achieved a net operating return on average tangible common shareholders’ equity of 18.17% for the full year.  Our core capital position strengthened, as the Tier 1 common ratio grew to 9.25% at the 2013 year-end, up 17 basis points from September 30 and 168 basis points higher than at December 31, 2012.  We are also pleased with the continued improvement in credit quality.  M&T’s liquidity and risk profile was enhanced during the year through several actions, including replacing less liquid investment securities with Ginnie Mae securities and the securitization of loans held in the loan portfolio.  During the final two quarters of 2013 we invested heavily in several key areas, including risk management, capital planning and stress testing, regulatory compliance, and other operational and technology initiatives.  Those investments will better position M&T for the future.”

    No Dividend Change

    MTB did not announce a change to its quarterly dividend, and has not raised its dividend since 2007. It should be noted that MTB did no! t cut its! dividend

  • source from Top Stocks For 2015:http://www.topstocksblog.com/10-best-bank-stocks-to-buy-right-now-4.html

Friday, July 24, 2015

Top 5 Paper Stocks To Buy For 2016

Top 5 Paper Stocks To Buy For 2016: Rock-Tenn Co (RKT)

Rock-Tenn Company (RockTenn), incorporated on September 20, 1985, is a North America's integrated manufacturer of corrugated and consumer packaging. The Company operates locations in the United States, Canada, Mexico, Chile, Argentina, Puerto Rico and China. The Company operates in three segments: Corrugated Packaging, consisting of its containerboard mills and its corrugated converting operations; Consumer Packaging, consisting of its coated and uncoated paperboard mills, consumer packaging converting operations and merchandising display facilities, and Recycling, which consists of its recycled fiber brokerage and collection operations. On June 22, 2012, the Company acquired Mid South Packaging LLC. On October 28, 2011, the Company acquired four entities doing business as GMI Group.

Corrugated Packaging Segment

The Company is a producer of linerboard and corrugated medium (containerboard) measured by tons produced and a producer of graphics pre- printed linerboard in North America. It operates an integrated system, which manufactures containerboard, corrugated sheets, corrugated packaging and preprinted linerboard for sale to industrial and consumer products manufacturers and corrugated box manufacturers. It produces a range of corrugated containers designed to protect, ship, store and display products made to its customers' merchandising and distribution specifications. It also converts corrugated sheets into corrugated products ranging from one-color protective cartons to point-of-purchase packaging. Corrugated packaging is used to provide protective packaging for shipment and distribution of food, paper, health and beauty and other household, consumer, commercial and industrial products and in the case of graphically enhanced corrugated packaging for retail sale, particularly in club store locations and retail sale. It also ! provides structural and graphic design, engineering services, and custom and standard auto mated packaging machines, offering customers turn-key instal! lation, automation, line integration and packaging solutions. It feeds linerboard and corrugated medium into corrugators, which flutes the medium to specified sizes, glues the linerboard and fluted medium together and slits and cuts the resulting corrugated paperboard into sheets to customer specifications. Its container board mills and corrugated container operations are integrated with its containerboard production used internally by its corrugated container operations. During the fiscal year ended September 30, 2012 (fiscal 2012), sales of corrugated packaging products to external customers accounted for 65.7% of its net sales.

Consumer Packaging Segment

The Company operates an integrated system of coated recycled mills and a bleached paperboard mill, which produces paperboard for its folding carton operations and third parties. The Company is a manufacturer of folding cartons in North America measured by net sales. Its folding cartons are used t o package food, paper, health and beauty and other household consumer, commercial and industrial products for retail sale. It also manufactures express mail envelopes for the overnight courier industry. Folding cartons protect customers' products during shipment and distribution and employ graphics to promote them at retail. It manufactures folding cartons from recycled and virgin paperboard, laminated paperboard and substrates with specialty characteristics, such as grease masking and microwaveability. It prints, coats, die-cuts and glues the cartons to customer specifications. It ships finished cartons to customers for assembling, filling and sealing. It employs a range of offset, flexographic, gravure, backside printing, and coating and finishing technologies. It supports its customers with package development, innovation and design services and package testing services.

!

The Company manufactures temporary and permanent point-of-purchase displays. The Compan y designs, manufactures and packs temporary displays for sal! e to cons! umer products companies. These displays are used as marketing tools to support new product introductions and specific product promotions in mass merchandising stores, supermarkets, convenience stores, home improvement stores and other retail locations. It also designs, manufactures and pre-assemble permanent displays for the same categories of customers. It makes temporary displays from corrugated paperboard. It provides contract packing services, such as multi-product promotional packing and product manipulation, such as multipacks and onpacks. The Company manufactures lithographic laminated packaging for sale to its customers, which require packaging with graphics and strength characteristics.

The Company operates an integrated system of specialty recycled paperboard mills, which includes its Seven Hills Paperboard LLC (Seven Hills) joint venture. Its specialty recycled paperboard mills, excluding Seven Hills, produce paperboard for its solid fiber interior pa ckaging converting operations and third parties, and its Seven Hills joint venture manufactures gypsum paperboard liner for sale to its joint venture partner. It sells its specialty recycled paperboard to manufacturers of solid fiber interior packaging, tubes and cores, and other paperboard products. It also converts specialty paperboard into book covers and other products. Its 65% owned subsidiary, RTS, designs and manufactures solid fiber and corrugated partitions and die-cut paperboard components. It manufactures and sells its solid fiber and corrugated partitions principally to glass container manufacturers and producers of beer, food, wine, spirits, cosmetics and pharmaceuticals and to the automotive industry. During fiscal 2012, sales of consumer packaging products to external customers accounted for 27.5% of its net sales.

Recycling Segment

The C! ompany's recycled fiber brokerage and collection operations provide a strategic advantage to its mills. Its recycling operations procure recovered paper (or! recycled! fiber) for its paper mills, as well as for third parties from factories, warehouses, commercial printers, office complexes, grocery and retail stores, document storage facilities, paper converters and other wastepaper collectors. It handles a range of grades of recovered paper, including old corrugated containers, office paper, box clippings, newspaper and print shop scraps. It operates recycling facilities, which collects, sorts, grades and bales recovered paper and after sorting and baling, it transfer recovered paper to its paperboard mills for processing, or sell it to the United States manufacturers of paperboard, as well as manufacturers of tissue, newsprint, roofing products and insulation and to export markets. It also collects aluminum and plastics for resale to manufacturers of these products. Its waste reduction services extract additional recyclables from the waste stream by working with customers. In addition, it operates a nationwide fiber marketing and broker age system, which serves regional and national accounts, as well as its recycled paperboard and containerboard mills and sells scrap materials from its converting businesses and mills. Brokerage contracts provide bulk purchasing. Its recycling facilities are located close to its recycled paperboard and containerboard mills, ensuring availability of supply with reduced shipping costs. During fiscal 2012, sales to external customers accounted for 6.8% of its net sales.

Advisors' Opinion:
  • [By BLOGS.BARRONS.COM]

    Ng writes that MLP creation could produce 30% to 50% gains in three stocks: International Paper (IP), Packaging Corp. of America (PKG) and Rock-Tenn Co. (RKT).  International Paper shares are up 2% this morning to 47.67; Packaging Corp. is 2% higher at 63.69 and Rock-Tenn is up 1.5% to 47. He continues:

  • [By ! Ben Levis! ohn]

    Shares of MeadWestvaco have jumped 4.6% to $37.29 today at 3:36 p.m. Other paper packaging companies, however, aren’t getting a boost from the news or from Merrill’s upgrade. Shares of Rock-Tenn (RKT) have dipped 0.1% to $100.34, International Paper (IP) has ticked up 0.1% to $48.74and Packaging Corp. of America (PKG) is little changed at $65.40.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/top-5-paper-stocks-to-buy-for-2016.html

Tuesday, July 21, 2015

Top Railroad Stocks To Invest In 2016

Top Railroad Stocks To Invest In 2016: Integra LifeSciences Holdings Corp (IART)

Integra LifeSciences Holdings Corporation (Integra), incorporated on June 19, 1989, is an integrated medical technology company. Integra offers solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. The Company has developed numerous product lines for applications ranging from burn and deep tissue wounds to regeneration of dura mater in the brain and repair of nerve and tendon. It operates in five business segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. The International segment sells similar products to Europe, Middle East and Africa, and Central/South America, Asia-Pacific and Canada. On April 29, 2013, the Company launched the Integra Compact Cranial Closure System, which provides titanium implants for non-loadbearing (non-facial) operative cranial neurosurgical procedures. On April 30, 2013, it released its Hollywood VI intervertebral body fusion device (I BD) system. In January 2014, Integra LifeSciences Holdings Corp completed the acquisition of DuraSeal product lines from Covidien. In January 2014, Covidien PLC completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation.

U.S. Neurosurgery

The Company's U.S. Neurosurgery sales organization sells a full line of products for neurosurgery and neuro critical care. It has products for each step of a cranial procedure and the care of the patient after surgery. Its key products include dural repair products, cerebral spinal fluid (CSF) management devices, tissue ablation equipment, intracranial monitoring equipment and cranial stabilization equipment. The Company sells equipment used in the neurosurgery operating room and neurosurgery intensive care unit (NICU).

U.S. Extremities

Extremity reconstruction includes the repair of soft tissue and the orthopedic reconstruction of bone in the foot, an kle and leg below the knee (Lower Extremity), and the hand, ! wrist, elbow and shoulder (Upper Extremity). Its key products include bone and joint fixation devices, implants and instruments for osteoarthritis, rheumatoid arthritis, wrist arthroplasty, carpel tunnel syndrome, and cubital tunnel syndrome. Other key products include its regenerative medicine devices for the treatment of acute and chronic wounds, peripheral nerve repair and protection and tendon repair, and bone graft substitutes.

U.S. Instruments

Integra's U.S. Instruments business is a surgical instrument suppliers in the United States. Its portfolio includes over 60,000 instrument patterns and surgical products sold a range of users, including hospitals, surgery centers, and physician, dental and veterinary offices. In addition to selling hand-held instruments, it sells surgical headlight systems and table-mounted retractors. The Company's brands include Jarit, Miltex, Padgett, Ruggles, Luxtec and Omni-Tract.

U.S. Spine and Oth er

Integra's U.S. Spine and Other segment offer spinal fusion technologies that surgeons use along the full length of the spine, as well as a range of related orthobiologics. During the year ended December 31, 2012, its Spine business launched multiple new implants into the integrated interbody fusion device market and the deformity market. Its key spinal hardware products include integrated interbody fusion devices, minimally invasive solutions, and deformity correction. It markets and sells a complete line of orthobiologics, including demineralized bone products, collagen ceramic matrices and pure synthetic bone grafting solutions, to neurosurgeons, and spine, orthopedic, trauma, and foot and ankle surgeons. Integra sells its products through specialty distributors focused on its spine and orthopedic surgeon customers, as well as thro! ugh some ! direct sales representatives. This segment also includes private-label sales of a set of its regenerative medicine te chnologies. Its customers are other large medical technology! companie! s that sell to end markets primarily in orthopedics and wound care.

The Company competes with Johnson & Johnson, Synthes, Inc., Stryker Corporation, Tornier, Inc., Wright Medical Group, Inc., Zimmer, Inc., Small Bone Innovations, Inc., Medtronic, Inc., Globus Medical Inc., NuVasive, Inc., Orthofix, Alphatec Spine, Inc., B. Braun Medical Inc., CareFusion and Symmetry Medical.

Advisors' Opinion:
  • [By Ben Levisohn]

    Shares of Align have surged 24% to $57 at 12:37 p.m. Sirona Dental Systems (SIRO) has risen 0.8% to $69.61, Dentsply International (XRAY) is up 0.1% at $45.44, Integra Lifesciences (IART) has  gained 0.4% to $44.23 and Danaher (DHR) has fallen 0.3% to $72.13.

  • [By Sean Williams]

    What: Shares of Integra LifeSciences (NASDAQ: IART  ) , a manufacturer of surgical instruments and medical implants, fell as much as 13% after the company announced a voluntary recall of certain products at its Anyasco manufacturing facility in Puerto Rico.

  • [By Keith Speights]

    Recall recoil
    Medical instrument maker Integra LifeSciences (NASDAQ: IART  ) shares dropped 11% this week. The stock's fall stemmed from a product recall announced on Wednesday. 

  • [By Seth Jayson]

    Basic guidelines
    In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Integra LifeSciences Holdings (Nasdaq: IART  ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Integra LifeSciences Holdings doing by this quick checkup? A! t first g! lance, OK, it seems. Trailing-12-month revenue increased 4.5%, and inventory increased 4.1%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue expanded 0.2%, and inventory increased 4.1%. Over the sequential quarterly period, the trend looks worrisome. Revenue dropped 8.3%, and inventory grew 4.5%.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/top-railroad-stocks-to-invest-in-2016.html

Sunday, July 19, 2015

Best Chemical Companies To Watch For 2016

Best Chemical Companies To Watch For 2016: Zoltek Companies Inc (ZOLT)

Zoltek Companies, Inc. is a holding company, which operates through wholly owned subsidiaries, Zoltek Corporation, Zoltek Zrt., Zoltek de Mexico SA de CV, Zoltek de Occidente SA de CV, Engineering Technology Corporation (Entec Composite Machines), Zoltek Properties, Inc., and Zoltek Automotive, LLC. Zoltek Corporation (Zoltek) develops, manufactures and markets carbon fibers and technical fibers in the United States. The Company is an applied technology and advanced materials company. It commercialization of carbon fiber through composites used in a range of commercial products, which it sells under the Panex trade name. In addition to manufacturing carbon fiber, it produces an intermediate product, a stabilized and oxidized acrylic fiber used in flame- and heat-resistant applications, which it sells under the Pyron trade name. During fiscal year ended September 30, 2011 (fiscal 2011), its net sales to Vestas Wind Systems, a wind turbine manufacturer represented % of its n et sales. In October 2011, Zoltek purchased a building in St. Peters, Missouri to house its prepreg operations.

Zoltek Zrt. is a Hungarian subsidiary that manufactures and markets carbon fibers and technical fibers and manufactures acrylic fiber precursor raw material used in production of carbon fibers and technical fibers. Zoltek de Mexico SA de CV and Zoltek de Occidente SA de CV are Mexican subsidiaries that manufacture carbon fiber and precursor raw material. Entec Composite Machines manufactures and markets filament winding and pultrusion equipment used in the production composite parts. The Company's sales markets are in Europe and the United States. The Company has manufacturing plants in Nyergesujfalu, Hungary, Guadalajara, Mexico, Abilene, Texas and St. Charles, Missouri. Its Texas plant houses carbon fiber manufacturing lines and value-ad! ded processing capabilities. Its Missouri plant is engaged in the production of technical fibers for aircraft bra ke and other friction applications and also produces limited! amounts of carbon fibers. In addition, it has facilities in Salt Lake City, Utah where it designs and builds composite manufacturing equipment and produce resin pre-impregnated carbon fibers, called prepregs. It performs certain downstream processing, such as weaving, knitting, blending with other fibers, chopping and milling and preparation of pre-form, pre-cut stacks of fabric. In addition, its Salt Lake City-based Entec Composite Machines subsidiary designs and builds composite manufacturing equipment and markets the equipment along with manufacturing technology and materials. It also provides composite design and engineering for development of applications for carbon fiber reinforced composites.

The Company competes with Hexcel Corporation, Cytec Industries, Toray Group, Toho Tenax, Mitsubishi Chemical and SGL Carbon.

Advisors' Opinion:
  • [By Maxx Chatsko]

    3. Zoltek (NASDAQ: ZOLT  )
    Zoltek was an interesting investment at the beginning of the year for futurist investors. The company is one of the largest manufacturers of carbon fiber in the world. In fact, its lightweight and high-strength carbon fiber is used almost exclusively in the largest wind turbine blades around the world and played a major role in America's 20-fold improvement in breezy energy capacity since 2000. This material of the future has many other uses and potential uses as well, but Zoltek has never really gained the confidence of the market in any big way: Its market cap was hovering near $300 million at the start of the year.

  • [By Maxx Chatsko]

    Shares of world-leading carbon fiber manufacturer Zoltek  (NASDAQ: ZOLT  )  have been pushed to new highs after a frantic attempt by Quinpario Partners to acquire a large position in the company. Despite being turned awa! y by mana! gement, the fund does make valid points about the company's general lack of progress given its global scope and potential. Investors in this business built around a game-changing material may be worrying whether shares are about to fall back to earth. In the following video, Fool.com contributor Maxx Chatsko gives at least one reason for investors to think that shares can hold their current levels -- or even trek higher.

  • [By Lauren Pollock]

    Toray Industries Inc.(3402.TO), the global market leader in carbon fiber, agreed to buy smaller rival Zoltek Cos.(ZOLT) in a deal valued at $584 million. The Japanese synthetic-fiber maker offered $16.75 a share, a 9.5% discount to Thurday’s close. Zoltek has struggled amid what it has called a cyclical downturn in the wind energy market. Zoltek shares dropped 10% to $16.58 in light premarket trading.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/best-chemical-companies-to-watch-for-2016.html

Friday, July 17, 2015

The 5 Dumbest Things on Wall Street This Week: Sept. 13

Carl's Not-So Sour Grapes

Excuse us for chuckling, Dumbest fans, but we simply cannot suppress our amusement over Carl Icahn's joke of a Tom Joad impression following his so-called Dell (DELL) defeat.

The billionaire activist investor announced on Monday he will discontinue his bid to derail Dell's near-$25 billion takeover by company founder Michael Dell and private equity firm Silver Lake Partners, after a string of legal rulings and decisions by Dell's special committee tasked with selling the struggling PC-maker turned against his competing proposals. Icahn's decision to throw in the towel essentially cements Michael Dell's and Silver Lake's takeover of the PC-maker, in what stands to be the biggest leveraged buyout since the financial crisis.

"I realize that some stockholders will be disappointed that we do not fight on. However, over the last decade, mainly through 'activism,' we have enhanced stockholder value in many companies by billions of dollars. We did not accomplish this by waging battles that we thought we would lose," wrote Icahn in a letter to Dell shareholders. Cut the crap, Carl. You didn't lose at all and you know it. The fruit of your Dell wrath is over $70 million smackers, according to the WSJ. So don't try and act like you are slurping sour grapes when everybody knows you're sucking down pricey champagne. As for your snide remark that you intend to call Michael Dell to wish him good luck because "he may need it," well, that certainly belies your stab at nobility. Or at the very least, it comes off as less than caring considering all the jobs soon to be shed at the struggling company you ostensibly were leading a charge to save. Ah, who are we trying to protect Carl? Let's be honest since you won't be. You didn't want to own Dell. You wanted a higher price without getting your hands dirty and that's exactly what you got when Michael bumped up his price to $13.75 a share and added that special 13-cent dividend. So please spare us the heartfelt concession speech. In fact, you wanted to own Dell as much as you wanted to own Yahoo! (YHOO) when you similarly stampeded into that humbled tech giant. Or, in other words, not one darned bit. We all know your tricks, Carl, and operating a company in earnest is not one of them. The only difference is that your dustup with Michael Dell ultimately took root and blossomed into lovely, verdant greenmail (albeit through a circuitous route via a Delaware court), while your battle with Jerry Yang turned out as dry as an Oklahoma dust storm when he refused your wish to sell the company to Microsoft (MSFT). Which brings us to our favorite line in Carl's farewell to Dell note, the one that harkens back to John Steinbeck's tale of itinerant woe. "If you are incensed by the actions of the Dell Board as much as I am, I hope you will choose to follow me on Twitter where from time to time I give my investment insights. I also intend to point out what I consider to be unconscionable actions by boards and discuss what remedies shareholders may take to change the situation," pronounced Icahn. Take heed, all you ordinary Americans out there, driving in your beaten-down cars across this hard land from sea to shining sea, Carl Icahn is there for you. Like the fictional, yet all-too-real migrant worker Tom Joad who vowed to fight social injustice "wherever you can look -- wherever there's a fight... wherever there's a cop beatin' up a guy," Carl Icahn will be there, too. He'll be standing by yours and Tom's side wherever a corporate board hoards cash and whenever a CEO attempts to take a company private with a lowball bid. Lest we forget Herbalife (HLF), his most wrathful pursuit of all. Yes, fellow citizens, Carl Icahn will be there for you wherever Bill Ackman is on the other side of the trade.

First Solar Stupidity

Remember the radio program where Paul Harvey would famously tell listeners "the rest of the story"?

Here's a 5 Dumbest version featuring our friends at First Solar (FSLR).

Back on Sept. 21, 2011, shares of the solar energy systems provider plummeted 7% after select analysts covering the company were informed it would not seek a $1.9 billion federal loan for its 550-megawatt Topaz project, one of the largest solar projects ever to be constructed. First Solar stock fell an additional 6% the following day, after it confirmed through a press release that the Topaz project would not receive a government loan guarantee. Because the institutions were able to act on the Topaz information prior to the general public, TheStreet reporter Eric Rosenbaum alertly asked the question on that second day of the selloff of whether First Solar had violated the Securities and Exchange Commission's Fair Disclosure Regulation, known on Wall Street as Reg FD, which stipulates that an officer or director of a company cannot make any disclosure of a material nature about its business on a selective basis. "Solar market insiders say that as many as five analysts were called on Wednesday by the head of First Solar investor relations, Larry Pollizotto, and told beginning Wednesday morning that First Solar might not get Topaz, but they felt good about the other two projects receiving loan guarantees," wrote Rosenbaum on Sept. 22, 2011, in a column titled "Did First Solar Just Walk a Fine Reg FD Line?" So what happened to First Solar in the two years since TheStreet broke the news that First Solar was keeping ordinary investors in the dark? That is, other than the stock going on a rollercoaster ride from $80 to $12 to $40? Well, last Friday the SEC charged Polizzotto, who is no longer with the company, with violating Reg FD on the matter. (For the record, Rosenbaum is no longer with TheStreet either.) Polizzotto agreed to pay $50,000 to settle the SEC's charges, without admitting or denying the findings. The SEC did not bring an enforcement action against First Solar because of "the company's extraordinary cooperation with the investigation among several other factors." (Also for the record, that's a load of crap.) "Polizzotto offered previously undisclosed information to select analysts and institutional investors and left the rest of First Solar's investors in the dark," Michele Wein Layne, director of the SEC's Los Angeles Office, said in a statement. "All investors, regardless of their size or relationship with the company, are entitled to the same information at the same time." And now you know the rest of a very, very dumb story.

5 Best Valued Stocks To Buy For 2016

Rick's Appeal

If you ask us, Rick's Cabaret (RICK) CEO Eric Langan ought to walk a mile in one of his dancers' 4-inch stilettos before whining about paying them minimum wage.

A federal judge ruled Tuesday that exotic dancers at Rick's midtown Manhattan strip club should be paid a minimum wage, proclaiming that the club unfairly classified Rick's dancers as independent contractors as opposed to club employees. A group of Rick's finest sued a subsidiary of the company in a class action in 2009, saying they received "performance fees" of $20 a pop for lap dances instead of salaries, despite adhering to the strict guidelines set by the company.

The ruling follows a string of similar decisions regarding the rights of topless talent and opens the door for 1,900 current and former Rick's Cabaret dancers to seek back wages from the club. Rick's is appealing the decision and moving that the class be decertified. Shares of Rick's, which owns and operates over 40 jiggle joints and restaurants across the country, sank nearly 2% Wednesday. "Unlike shoe-shine employees at an airport, topless dancers are the 'main attraction' at a topless nightclub and obviously very important to the business of the nightclub," wrote U.S. District Judge Paul Engelmayer, adding that Rick's draconian rules forbade chewing gum, "bad attitudes" and body glitter. We heartily agree, your honor. And we can only imagine the difficulty you faced in visualizing this case, especially when you were forced to examine exhibits A through double D. Rick's legal team contended that the cash earned for lap dances counted as wages. Langan also argued that dancers who can stuff up to $1,000 dollars in their pockets, er, panties on a good night are too well compensated to deserve the minimum wage. Engelmayer, however, didn't buy Rick's wage argument and he actually cited Langan's own pretrial deposition statement that "the most important thing to the Rick's Cabaret brand is that it has entertainers" in his decision. "Without the girls, we're just selling overpriced beers at a sports bar with bad TVs," said Langan in his testimony. Nice going, Eric, way to sink your own case. Here's a tip for you: Pay the money and let it go. You've already changed your corporate labor practices so this type of occurrence won't happen again. And as you mentioned in your press release, this verdict affects a subsidiary of yours, not the parent company. The only thing you are doing by pushing this case any further is directing attention to yourself and not your company's asses, er, assets.

Ova And Out

Note to the geniuses at OvaScience (OVAS): Overlooking the FDA when launching a new drug is generally not a keen idea. In fact, it's overwhelmingly dumb.

The biotech company's stock was overrun by sellers Wednesday, sinking over 21% to $11 after the company said federal regulators are inquiring about the status of its fertility treatment Augment. The FDA instructed OvaScience to file an investigational new drug application for the product, which would require additional rounds of testing and will likely keep Augment off the U.S. market for years.

In a press release, OvaScience announced it was suspending enrollment of Augment trials in the U.S. while it has further discussions with the FDA. In the meantime, the company said it is moving forward with plans for enrollment outside of the country. Put simply, OvaScience believed Augment was a cellular- and tissue-based product, also known as a 361 HCT/P, and, as such, could be marketed commercially without FDA oversight or review as drug. As a result, the company -- knowingly or unknowingly -- neglected to ask the FDA if it agreed with its characterization of Augment and proceeded until the FDA shut it down. Or, in even simpler terms, OvaScience tried an end-around, but its FDA overlords put an end to it. Worst of all, the company's stock was in overdrive prior to its being sucked under. OvaScience shares closed Tuesday at $14.28, up more than 70% for the year. Also, just last week Wedbush analyst Zarak Khurshid initiated coverage of the company with an "outperform" rating and a $20 target. That very same day, the company's CEO Dr. Michelle Dipp triumphantly rang the opening bell at the Nasdaq. We have a feeling that Khurshid is thinking that OvaScience outperform over right now. Don't you think?

This weekend is the fifth anniversary of Lehman Brothers filing for bankruptcy. To mark the less-than-auspicious occasion, we are reprinting the Lehman entry from our Sept. 19, 2008 list. Enjoy the trip down Dumbest lane! Lamenting Lehman

"It's a tragedy ... Bobbie (Lehman) is spinning in his grave."

That's what long-time Lehman Brothers partner Herman Kahn said following the firm's sale to Shearson/Amex in 1984, according to Greed and Glory on Wall Street: The Fall of the House of Lehman by Ken Auletta. If he was rolling over then, one can only imagine what Bobbie's doing now. He should be haunting former CEO Dick Fuld for driving the 158-year-old firm into the ground. With so much stupidity still swirling around Lehman's sudden demise, the Five Dumbest Lab selected a few items too good to pass up before saying our final goodbyes: Leaving on Top: Institutional Investor awarded Lehman Brothers the top spot this week in its annual All-America Fixed Income Research Team rankings, defending its title for the ninth straight year. Bove's Bungle: "I still believe that this is one of the best companies on Wall Street and that it has value well beyond its current stock price. Therefore, the stock remains a buy," said Ladenburg Thalmann analyst Dick Bove on Sept. 11 with the stock's price at $7.25 and sinking. Asleep at the Board: What's especially revealing about Lehman's demise is the average age of its 10-member board: 74.3 years. Their backgrounds are even more revealing. Counted among the board are such business bastions as a theater producer and a Navy admiral. Anyone still wondering why things fell apart? We won't even ask if anyone believes they earned the $360,000 in average compensation they received. Waxman Pathetic: "Our hearings will examine what went wrong and who should be held to account," Henry Waxman, the Democratic congressman from Los Angeles, said Wednesday when he announced hearings that will include Dick Fuld and former AIG (AIG) CEOs Robert Willumstad and Maurice "Hank" Greenberg. That's the kind of decisive response we've come to expect from Congress. Fuld's Farewell: "The past several months have been extraordinarily challenging. For some of you, the firm has been your home for decades. For others, less than a year. For all of us, it has been far more than a place of employment. It has been a source of pride." Email from Richard Fuld, CEO of Lehman Brothers, 1994-2008. Yes, Dick, you've got plenty to be proud of. -- Written by Gregg Greenberg in New York Follow @5gsonthestreet

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Tuesday, July 14, 2015

Top 10 Construction Material Stocks To Invest In 2016

Top 10 Construction Material Stocks To Invest In 2016: Boral Ltd (BLD)

Boral Limited (Boral), is engaged in the manufacture and supply of building and construction materials in Australia, the United States and Asia. The Company's operating segments include Construction Materials & Cement, Building Products, Boral Gypsum, and Boral USA. The Construction Materials & Cement is engaged in quarries, concrete, asphalt, transport, landfill, property, cement and concrete placing. The Building Products segment is engaged in Australian bricks, roof tiles, masonry, timber products and windows. The Boral Gypsum involves Australian and Asian plasterboard. The Boral USA is engaged in Bricks, cultured stone, roof tiles, fly ash, concrete and quarries. Advisors' Opinion:
  • [By Eric Lam]

    Ballard Power (BLD), which designs and manufactures hydrogen fuel cells, slumped 15 percent to C$1.42, the biggest decline since March. The company yesterday said it will sell about 9 million units at $1.40 a unit for proceeds of about $12.6 million. The cash generated will be used to fund working capital, support growth and general corporate purposes, the company said.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-construction-material-stocks-to-invest-in-2016.html

Thursday, July 9, 2015

Best Long Term Companies To Buy For 2016

Best Long Term Companies To Buy For 2016: PTC Therapeutics Inc (PTCT)

PTC Therapeutics, Inc., incorporated on March 31, 1998 , is a biopharmaceutical company focused on the discovery and development of orally administered, small-molecule drugs that target post-transcriptional control processes. The Company's lead product candidate includes ataluren, which is used for the treatment of patients with genetic disorders that arise from a type of genetic mutation known as a nonsense mutation. Ataluren is in late stage clinical development for the treatment of Duchenne muscular dystrophy caused by nonsense mutations (nmDMD) and cystic fibrosis caused by nonsense mutations (nmCF).

Ataluren is orally administered small-molecule compound that targets nonsense mutations. The Company is engaged in the development of ataluren for the treatment of genetic disorders in, which a nonsense mutation is the cause of the disease. Genetic tests are available for many genetic disorders, including Duchenne muscular dystrophy and cystic fibrosis, to d etermine if the underlying cause is a nonsense mutation. The EMA has designated ataluren as an orphan medicinal product for the treatment of nmDMD and nmCF. During the year ended December 31, 2012, the Phase III clinical trial completed. The Company's Ataluren clinical trials in patients with nonsense mutation genetic disorders include Ataluren for nmDMD: Phase 2b clinical trial complete; Confirmatory Phase III clinical trial initiated, and Ataluren for nmCF: Phase III trial completed.

Advisors' Opinion:
  • [By WWW.DAILYFINANCE.COM]

    Records fell on Wall Street Friday as another solid report on housing lifted the market for the second day in a row. There's a three-day weekend coming up -- something that often prompts investor caution -- but the gains were broad-based even though volume was fairly light. The VIX, which measures volat! ility, fell to its lowest level this year. The Dow Jones industrial average (^DJI) gained 63 points, the Nasdaq composite (^IXIC) rose 31, and the Standard & Poor's 500 index (^GPSC) added 8, topping the record high set last week. The Dow Transportation average also raced to an all-time high, lifted by airline stocks. United (UAL) soared more than 4 percent; Delta (DAL) gained more than 1 percent and Southwest (LUV) gained 2 percent. Southwest is at an all-time high, up 79 percent from a year ago. New home sales bounced back with a better than expected 6.4 percent increase last month. Lennar (LEN) and D.R. Horton (DHI) both rose 4 percent. Pulte (PHM), Beazer (BZH) and Hovnanian (HOV) also solid posted gains. Earnings continue to drive retail stocks. Gap (GPS) edged higher even though net fell. Foot Locker (FL) gained 1½ percent after topping expectations. GameStop (GME) rose 4 percent. Its net rose, helped by the rollout last year of new Xbox and PlayStation consoles. Zumiez (ZUMZ) rose 5½ percent on an earnings beat. But Aeropostale (ARO) tumbled 24 percent. Its loss widened and sales declined. The retailer continues to struggle with teen fashion trends. Also on the earnings front, TiVo (TIVO) rose 2 percent as it swung to a profit from a year ago loss. It also reported an increase in the number of subscribers. Hewlett-Packard (HPQ) rose 6 percent on news the company plans to eliminate up to 16,000 additional workers in an effort to cut costs. And several stocks extended big moves from yesterday. Best Buy (BBY) rose more than 3 percent for the second straight day after earnings beat expectations. Isis Pharmaceuticals (ISIS) jumped
  • [By John Kell]

    PTC Therapeutics Inc.(PTCT) said the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative opinion on the biopharmaceutical company’s marketing authorization application for its muscular dystrophy treatment. Shares slumped 21% to $20.60 in premarket trading.

    s! ource from Top Stocks For 2015:http://www.topstocksblog.com/best-long-term-companies-to-buy-for-2016.html